Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Hepatology. 2010 Sep;52(3):1111-23. doi: 10.1002/hep.23793.
We previously reported that forced expression of Bmi1 (B lymphoma Moloney murine leukemia virus insertion region 1 homolog) in murine hepatic stem/progenitor cells purified from fetal liver enhances their self-renewal and drives cancer initiation. In the present study, we examined the contribution of the Ink4a/Arf tumor suppressor gene locus, one of the major targets of Bmi1, to stem cell expansion and cancer initiation. Bmi1(-/-) Delta-like protein (Dlk)(+) hepatic stem/progenitor cells showed de-repression of the Ink4a/Arf locus and displayed impaired growth activity. In contrast, Ink4a/Arf(-/-) Dlk(+) cells gave rise to considerably larger colonies containing a greater number of bipotent cells than wild-type Dlk(+) cells. Although Ink4a/Arf(-/-) Dlk(+) cells did not initiate tumors in recipient nonobese diabetic/severe combined immunodeficiency mice, enforced expression of Bmi1 in Ink4a/Arf(-/-) Dlk(+) cells further augmented their self-renewal capacity and resulted in tumor formation in vivo. Microarray analyses successfully identified five down-regulated genes as candidate downstream targets for Bmi1 in hepatic stem/progenitor cells. Of these genes, enforced expression of sex determining region Y-box 17 (Sox17) in Dlk(+) cells strongly suppressed colony propagation and tumor growth.
These results indicate that repression of targets of Bmi1 other than the Ink4a/Arf locus plays a crucial role in the oncogenic transformation of hepatic stem/progenitor cells. Functional analyses of Bmi1 target genes would be of importance to elucidate the molecular machinery underlying hepatic stem cell system and explore therapeutic approaches for the eradication of liver cancer stem cells.
我们之前报道过,在从胎肝中纯化的鼠肝干细胞/祖细胞中强制表达 Bmi1(B 淋巴瘤 Moloney 鼠白血病病毒插入区 1 同源物)会增强其自我更新能力,并促使癌症的发生。在本研究中,我们研究了 Ink4a/Arf 肿瘤抑制基因座(Bmi1 的主要靶标之一)对干细胞扩增和癌症起始的贡献。Bmi1(-/-)Delta-like 蛋白(Dlk)(+)肝干细胞/祖细胞显示 Ink4a/Arf 基因座去抑制,并表现出生长活性受损。相比之下,Ink4a/Arf(-/-)Dlk(+)细胞产生的含有更多双潜能细胞的较大集落比野生型 Dlk(+)细胞多得多。尽管 Ink4a/Arf(-/-)Dlk(+)细胞在受体非肥胖型糖尿病/严重联合免疫缺陷小鼠中不会引发肿瘤,但在 Ink4a/Arf(-/-)Dlk(+)细胞中强制表达 Bmi1 进一步增强了它们的自我更新能力,并导致体内肿瘤形成。微阵列分析成功鉴定出五个下调基因作为 Bmi1 在肝干细胞/祖细胞中的候选下游靶标。在这些基因中,在 Dlk(+)细胞中强制表达性别决定区 Y 框 17(Sox17)强烈抑制集落增殖和肿瘤生长。
这些结果表明,除了 Ink4a/Arf 基因座之外,Bmi1 靶基因的抑制在肝干细胞/祖细胞的致癌转化中起着关键作用。对 Bmi1 靶基因的功能分析对于阐明肝干细胞系统的分子机制以及探索消除肝癌干细胞的治疗方法将具有重要意义。